Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 478,468 |
|
|||||
| News | - | ||||||
| Day High | 43.80 | Low High |
|||||
| Day Low | 42.77 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| EXACT Sciences Corporation | EXAS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -1.28 | -2.85% | 43.395 | 10:57:16 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 42.92 | 42.77 | 43.80 | 44.67 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,817 | 478,468 | US$ 43.38 | US$ 20,754,804 | - | 42.77 - 100.77 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 10:57:31 | 1 | US$ 43.40 | USD |
EXACT Sciences (EXAS) Options Flow Summary
EXACT Sciences Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.89B | 181.53M | - | 2.58B | -204.15M | -1.12 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
EXACT Sciences News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/03/2024 | 06:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/28/2024 | 05:00 | Business Wire | Exact Sciences to Participate in June Investor Conferences |
| 5/25/2024 | 06:32 | Business Wire | ASCO®: Exact Sciences bekräftigt mit mehreren.. |
| 5/24/2024 | 11:46 | Business Wire | Exact Sciences démontre son leadership continu en matière de.. |
| 5/24/2024 | 05:05 | Business Wire | Exact Sciences Demonstrates Continued Leadership in Early.. |
| 5/22/2024 | 06:30 | Business Wire | Exact Sciences Earns 2024 Great Place To Work®.. |
| 5/21/2024 | 05:05 | Business Wire | Court Ruling Enables Exact Sciences to Proceed with Lawsuit.. |
| 5/20/2024 | 15:30 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 5/08/2024 | 16:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/08/2024 | 16:08 | Edgar (US Regulatory) | Form 424B7 - Prospectus [Rule 424(b)(7)] |
| 5/08/2024 | 16:03 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 5/08/2024 | 15:08 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EXAS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 45.32 | 47.19 | 42.77 | 44.79 | 2,087,125 | -1.93 | -4.25% |
| 1 Month | 54.41 | 56.79 | 42.77 | 50.22 | 3,460,439 | -11.02 | -20.24% |
| 3 Months | 58.13 | 79.62 | 42.77 | 59.71 | 3,122,737 | -14.74 | -25.35% |
| 6 Months | 65.27 | 79.62 | 42.77 | 61.66 | 2,492,814 | -21.88 | -33.51% |
| 1 Year | 86.00 | 100.77 | 42.77 | 68.12 | 2,001,744 | -42.61 | -49.54% |
| 3 Years | 107.54 | 133.99 | 29.27 | 66.21 | 1,996,923 | -64.15 | -59.65% |
| 5 Years | 105.39 | 159.54 | 29.27 | 79.30 | 1,937,622 | -62.00 | -58.82% |
EXACT Sciences Description
| Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of earliest entrants in multi-cancer liquid biopsy cancer screening. |
